ASML’s Market Supremacy Faces a New Challenge
22.12.2025 - 09:04:04Asml NL0010273215
As the holiday week begins, ASML finds itself balancing on a knife's edge. The Dutch semiconductor equipment giant is simultaneously demonstrating its unparalleled technological prowess and confronting emerging geopolitical concerns that threaten its long-held monopoly. While the company celebrates a critical milestone with Intel, reports of a state-backed Chinese initiative are introducing fresh uncertainty for investors.
Despite headlines focusing on potential competition, institutional investors have been increasing their stakes. Recent data reveals that asset managers, including Red Door Wealth Management, significantly expanded their positions in ASML during the third quarter. This accumulation suggests that professional investors currently view the company's formidable earnings power as outweighing longer-term geopolitical risks.
The stock's performance reflects this underlying strength. Currently trading at €908.40, ASML shares maintain a robust yearly gain of nearly 33%, even though the price sits approximately 7% below its 52-week peak. This valuation is supported by a positive industry outlook. The SEMI industry association forecasts a 9% rise in global equipment sales for 2026, driven largely by the expansion of artificial intelligence capacity. Furthermore, recent guidance from Micron confirms an accelerating demand for memory chips, which directly fuels the need for ASML's advanced lithography systems.
A Display of Unmatched Technological Capability
The core of ASML's dominance remains secure for now. The company has achieved a decisive step forward, with Intel successfully installing the first commercial High-NA EUV system, known as the Twinscan EXE:5200B. This machine, which processes wafers with unprecedented precision, is set to form the backbone of semiconductor manufacturing roadmaps for the next decade.
Should investors sell immediately? Or is it worth buying Asml?
In a sign of the technology's versatile potential, research institute IMEC demonstrated on Sunday the fabrication of biomedical sensors using ASML's equipment. The company itself has categorized this development as an unexpected opportunity within high-value niche applications, potentially opening new markets.
The Emergence of a Potential Rival
The positive narrative, however, is being tested by news from China. Reports indicate that a state-supported project in Shenzhen, likened to a "Manhattan Project," has developed a working prototype of an EUV light source. Market observers interpret this as a direct challenge to ASML's monopoly. Although analysts believe mass production using this technology is not realistic before 2028-2030, the mere existence of the prototype chips away at the thesis of the company's absolute indispensability.
Technically, the stock is in a consolidation phase. The immediate trajectory now hinges on whether the market dismisses the Chinese prototype as a distant prospect and refocuses on the successful integration of ASML's next-generation High-NA systems. The majority of analysts maintain a positive rating on the equity, viewing the current price level as an opportunity rather than a structural warning signal.
Ad
Asml Stock: Buy or Sell?! New Asml Analysis from December 22 delivers the answer:
The latest Asml figures speak for themselves: Urgent action needed for Asml investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 22.
Asml: Buy or sell? Read more here...


